The significance of p53 and bcl-2 overexpression and other prognostic factors in transitional cell carcinoma of the bladder

被引:6
作者
Touloupidis, Stavros [1 ]
Fatles, Georgios
Kalaitzis, Christos
Giatromanolaki, Alexandra
Sivridis, Eythimyos
Simopoulos, Konstantinos
Rombis, Vassilios
机构
[1] Democritus Univ Thrace, Dept Urol, Alexandroupolis 68100, Greece
[2] Ippokratio Hosp Thessaloniki, Dept Urol, Thessaloniki, Greece
[3] Democritus Univ Thrace, Dept Pathol, Alexandroupolis 68100, Greece
[4] Democritus Univ Thrace, Dept Surg 2, Alexandroupolis 68100, Greece
关键词
bcl-2; p53; transitional cell carcinoma of the bladder;
D O I
10.1007/s11255-005-4763-3
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study was to investigate the expression of bcl-2 and p53 oncoproteins in a series of transitional cell bladder carcinomas and its relation to traditional prognostic indicators and patients' survival. Specimens from 59 patients who underwent transurethral resection from March 1992 to February 1997 were included in this study. Tumors were graded based on WHO grades 1-3 and staged according to the 1997 TNM classification. Three patients lost to follow-up were excluded from the analysis. We could not establish a statistically significant relation between bcl-2 and p53 and other parameters such as sex, age, stage and grade. Tumor grade and stage were the most important factors for predicting tumor recurrence and aggressiveness. Only sex seems to significantly affect the statistics of the risk of death (p < 0.05). Women had quadruple risk of death compared to men.
引用
收藏
页码:231 / 236
页数:6
相关论文
共 20 条
[1]   Bcl-2 and p53 overexpression as associated risk factors in transitional cell carcinoma of the bladder [J].
Atuǧ F. ;
Türkeri L. ;
Özyürek M. ;
Akdaş A. .
International Urology and Nephrology, 1998, 30 (4) :455-461
[2]  
BURKHARD FC, 1997, UROL RES, V25, P31
[3]  
CordonCardo C, 1997, SEMIN SURG ONCOL, V13, P319, DOI 10.1002/(SICI)1098-2388(199709/10)13:5<319::AID-SSU5>3.0.CO
[4]  
2-G
[5]   ACCUMULATION OF NUCLEAR P53 AND TUMOR PROGRESSION IN BLADDER-CANCER [J].
ESRIG, D ;
ELMAJIAN, D ;
GROSHEN, S ;
FREEMAN, JA ;
STEIN, JP ;
CHEN, SC ;
NICHOLS, PW ;
SKINNER, DG ;
JONES, PA ;
COTE, RJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (19) :1259-1264
[6]   Detection of loss of heterozygosity in the p53 tumor-suppressor gene with PCR in the urine of patients with bladder cancer [J].
Friedrich, MG ;
Erbersdobler, A ;
Schwaibold, H ;
Conrad, S ;
Huland, E ;
Huland, H .
JOURNAL OF UROLOGY, 2000, 163 (03) :1039-1042
[7]   BCL-2 IS AN INNER MITOCHONDRIAL-MEMBRANE PROTEIN THAT BLOCKS PROGRAMMED CELL-DEATH [J].
HOCKENBERY, D ;
NUNEZ, G ;
MILLIMAN, C ;
SCHREIBER, RD ;
KORSMEYER, SJ .
NATURE, 1990, 348 (6299) :334-336
[8]   Expression of bcl-2 and bcl-X in bladder cancer [J].
Kirsh, EJ ;
Baunoch, DA ;
Stadler, WM .
JOURNAL OF UROLOGY, 1998, 159 (04) :1348-1353
[9]   Reciprocal expression of bcl-2 and p53 oncoproteins in urothelial dysplasia and carcinoma of the urinary bladder [J].
Li, BY ;
Kanamaru, H ;
Noriki, S ;
Yamaguchi, T ;
Fukuda, M ;
Okada, K .
UROLOGICAL RESEARCH, 1998, 26 (04) :235-241
[10]   Expression of the apoptosis suppressing bcl-2 protein in transitional cell bladder tumours [J].
Lipponen, PK ;
Aaltomaa, S ;
Eskelinen, M .
HISTOPATHOLOGY, 1996, 28 (02) :135-140